Al-Modawat Specialized Medical Co (SAU:9594) EBITDA Margin %: 18.18% (As of Mar. 2026) — 19% Below Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SAU:9594 Al-Modawat Specialized Medical Co SAU:9594
21 GF Score
Price ﷼5.59
! 2 Warning Signs
View Full Analysis

What is Al-Modawat Specialized Medical Co EBITDA Margin %?

Al-Modawat Specialized Medical Co SAU:9594 21 EBITDA Margin % is 18.18% as of Mar. 2026, which is 19% below its 10-year median of 22.50. GuruFocus rates SAU:9594 with a GF Score™ of 21/100. The stock has 2 warning signs investors should review. Among 664 Healthcare Providers & Services companies, Al-Modawat Specialized Medical Co ranks better than 73.19% on this metric.

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Al-Modawat Specialized Medical Co's EBITDA for the three months ended in Mar. 2026 was ﷼6.3 Mil. Al-Modawat Specialized Medical Co's Revenue for the three months ended in Mar. 2026 was ﷼34.9 Mil. Therefore, Al-Modawat Specialized Medical Co's EBITDA margin for the quarter that ended in Mar. 2026 was 18.18%.


Al-Modawat Specialized Medical Co  (SAU:9594) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Al-Modawat Specialized Medical Co EBITDA Margin % Related Terms


Al-Modawat Specialized Medical Co EBITDA Margin % Historical Data

* Premium members only.

The historical data trend for Al-Modawat Specialized Medical Co's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Al-Modawat Specialized Medical Co EBITDA Margin % Chart

Al-Modawat Specialized Medical Co Annual Data
Trend Dec22 Dec23 Dec24 Dec25
EBITDA Margin %
19.72 27.95 18.52 25.28

Al-Modawat Specialized Medical Co Quarterly Data
Dec22 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 27.80 20.82 15.30 23.31 18.18

SAU:9594 vs HCA, THC, DVA: EBITDA Margin % Comparison

For the Medical Care Facilities subindustry, Al-Modawat Specialized Medical Co's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Al-Modawat Specialized Medical Co EBITDA Margin % vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Al-Modawat Specialized Medical Co's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Al-Modawat Specialized Medical Co's EBITDA Margin % falls into.


SAU:9594
21GF Score
Al-Modawat Specialized Medical Co SAU:9594
EBITDA Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Al-Modawat Specialized Medical Co EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Al-Modawat Specialized Medical Co's EBITDA Margin % for the fiscal year that ended in Dec. 2025 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=30.792/121.821
=25.28 %

Al-Modawat Specialized Medical Co's EBITDA Margin % for the quarter that ended in Mar. 2026 is calculated as

EBITDA Margin %=EBITDA (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=6.347/34.906
=18.18 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBITDA Margin % →
What does a EBITDA Margin % of 18.18% mean?
Al-Modawat Specialized Medical Co (SAU:9594) has a EBITDA Margin % of 18.18% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Al-Modawat Specialized Medical Co and its competitors. This is 19% below median its historical median of 22.50. Over the past decade, Al-Modawat Specialized Medical Co's EBITDA Margin % has ranged from 18.52 to 27.95. According to the industry distribution chart, Al-Modawat Specialized Medical Co ranks #178 out of 664 companies in the Healthcare Providers & Services industry, placing it in the top 26.8%.
Is Al-Modawat Specialized Medical Co's EBITDA Margin % too high?
Al-Modawat Specialized Medical Co's current EBITDA Margin % of 18.18% is 19% below median its 10-year median of 22.50. Over the past 10 years, this metric has ranged from a low of 18.52 to a high of 27.95. The Healthcare Providers & Services industry median EBITDA Margin % is 10.21. Al-Modawat Specialized Medical Co's value of 18.18% is 78.1% above this industry median. Based on the distribution chart, Al-Modawat Specialized Medical Co ranks #178 out of 664 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Al-Modawat Specialized Medical Co has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.
How does Al-Modawat Specialized Medical Co's EBITDA Margin % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Al-Modawat Specialized Medical Co ranks #178 out of 664 companies for EBITDA Margin %. This puts Al-Modawat Specialized Medical Co in the upper half of its industry. The industry median EBITDA Margin % is 10.21. Al-Modawat Specialized Medical Co's value of 18.18% is 78.1% above this benchmark. Historically, Al-Modawat Specialized Medical Co's own EBITDA Margin % has ranged from 18.52 to 27.95 over the past decade. While the company's 10-year median is 22.50 vs. the industry median of 10.21, Al-Modawat Specialized Medical Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Healthcare Providers & Services company?
The median EBITDA Margin % among Healthcare Providers & Services companies is 10.21, based on 664 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Al-Modawat Specialized Medical Co's current EBITDA Margin % of 18.18% is 78.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Al-Modawat Specialized Medical Co and its competitors. For the Healthcare Providers & Services industry, the median EBITDA Margin % is 10.21 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Al-Modawat Specialized Medical Co's current EBITDA Margin % is 18.18%, which is 19% below median its own 10-year median of 22.50. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Al-Modawat Specialized Medical Co stock overvalued right now?
Al-Modawat Specialized Medical Co (SAU:9594) has a current EBITDA Margin % of 18.18%. The current EBITDA Margin % is 18.18%, which is 19% below median its 10-year median of 22.50 and 78.1% above the Healthcare Providers & Services industry median of 10.21. Al-Modawat Specialized Medical Co's overall GF Score™ is 21/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Al-Modawat Specialized Medical Co (SAU:9594), the current EBITDA Margin % is 18.18% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Al-Modawat Specialized Medical Co Business Description

Address Kingdom of Saudi Arabia, P.O. Box 176, Muhayil, SAU
Al-Modawat Specialized Medical Co is a company engaged in Pharmacy activities, drug warehouse activities, other activities for selling pharmaceutical, medical and cosmetic products and retail toiletries in specialized stores, public hospitals.
21GF Score

Get the complete analysis for SAU:9594

EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

﷼5.59
Price